Mohammad Ghasemi Hamed, the innovative co-founder of Odyssey Neuroscience, is at the forefront of cognitive enhancement technology. His startup is pioneering the integration of personalized Transcranial Electrical Stimulation (TES) with advanced AI algorithms. Holding a Ph.D. in Computer Science and boasting extensive expertise in statistical learning and data science, Mohammad has adeptly bridged the gap between academic research and entrepreneurial innovation. His groundbreaking work has culminated in the creation of the world's first AI-powered, individualized cognitive enhancement platform. Drawing from his background as an AI researcher, Mohammad infuses scientific precision with entrepreneurial vision in the realm of neurotechnology. His passionate pursuit of unlocking human cognitive potential offers unique insights at the convergence of neuroscience, artificial intelligence, and the optimization of human performance.

Dr. Rajendra D. Badgaiyan, is Professor of Psychiatry at University of Texas Health San Antonio. After completing psychiatry residency training at Harvard Medical School, Dr Badgaiyan joined the faculty ofHarvard Medical School, State University of New York at Buffalo, and University of Minnesota.He also served as the Professor of Psychiatry and Chairman of the Department atthe hospital affiliated to Icahn School of Medicine at Mount Sinai, New York; Chief of Psychiatry at South Texas Healthcare System at San Antonio, TX and Chairman of Psychiatry department at Case Western Reserve University Cleveland. Dr Badgaiyan developed anovel Neurotransmitter Imaging technique for detection, mapping, and quantification of neurotransmitters released in the live human brain during performance of mental activities. Using this technique, he studies dopaminergic control of conscious and nonconsciouscognition and behavior and understanding neuropathology of psychiatric conditions. He received several prizes and awards for research including the prestigious Solomon Prize of Harvard Medical School and BK Anand National Research Prize in India. His research is funded by National Institutes of Health, Department of Veterans’ Affairs, Dana Foundation and other agencies. Dr Badgaiyan has published over 300 research papers and book chapters. He authored a book titled ‘Neuroscience of the Nonconscious Mind’ (Elsevier/Academic Press).

Prof. Marco Carotenuto obtained a master's degree in medicine and surgery at the University of Campania 'Luigi Vanvitelli,” Italy, in 2000. He became a specialist in child neuropsychiatry in 2005 after a long period of training in the United Kingdom. He also obtained a Ph.D. in Behavioral Sciences and Learning Disorders in 2008. In 2018, after further training at prestigious Italian research centres to delve deeper into diagnostic, therapeutic, and rehabilitative issues in developmental age, Dr. Carotenuto became a Professor of Child Neuropsychiatry and Director of the Child Neuropsychiatry Unit at the University of Campania 'Luigi Vanvitelli.” Since 2022, he has been the president of the National Commission for Neurotherapy and Psychomotor Therapy in Developmental Age (TNPEE). Since 2022, he has been Director of the School of Specialization in Child Neuropsychiatry, University of Campania 'Luigi Vanvitelli.” Dr. Carotenuto has authored more than 250 scientific journal articles.

Dr. Khue Vu Nguyen (born in Ha Noi, Viet Nam) is currently Visiting Professor in the School of Medical Imaging, Jiangsu Vocational College of Medicine, Yancheng 224005 Jiangsu, China, and collaborating for research work with the Centre for Molecular Biophysics from Centre National de la Recherche Scientifique, CNRS, at Orleans, 45071 Orleans, France. He was Full Project Scientist in the Departments of Medicine and Pediatrics, University of California, San Diego, School of Medicine, San Diego, California 92103, U.S.A. He has worked as Scientist in different French and U.S. Research Institutions and Companies. He has studied at University Louis Pasteur, Strasbourg, France: B.S. in Biochemistry; M.S. in Molecular Biology; Ph.D. in Macromolecular Physical Chemistry; Ph.D. in Physical Sciences (Doctorat d’Etat es Sciences Physiques). He is author and co-author of numerous publications and holder of many patents. He is listed in Who’s Who in the World; Who’s Who in America; Who’s Who in Science and Engineering; Who’s Who in Medicine and Healthcare. He is member of different academic organizations such as American Society for Microbiology; American Chemical Society. He is Editor-in-Chief of different scientific journals such as Current Pediatric Research; Enliven: Journal of Genetics, Molecular and Cellular Biology; Journal of Brain Research; etc. He is Editorial Board Member of different scientific journals such as Metabolic Brain Disease; Journal of Pediatric Genetics; Expert Opinion on Orphan Drugs; etc. He is also Invited Reviewer of different scientific journals such as Molecular Genetics and Metabolism; AGE: Journal of the American Aging Association; Journal of Neural Transmission; etc. He is Scientist Reviewer for grant proposals of the Metabolic Disease Two (MB-2) of the Peer Review Medical Research Program (PRMRP) for the U.S. Department of Defense Congressionally Directed Medical Research Programs (CDMRP). Current research includes genetic diseases, neurodevelopmental and neurodegenerative disorders, cardiovascular diseases, and cancer.

Dr. Michel Bourin, a distinguished medical professional, embarked on his academic journey at the University of Tours, where he earned his degrees in Medicine and Pharmaceutical Sciences in 1979 and 1970, respectively. His passion for pharmacology led him to pursue specialized degrees in Neuropsychopharmacology, Clinical Pharmacology, and General Pharmacology at the University of Paris from 1977 to 1978. Throughout his illustrious career, Dr. Michel Bourin has held various prestigious positions, including Psychiatrist certified by the National Committee of the French Medical Board in 1997. Presently, he serves as a dedicated Psychiatrist at a center for mentally handicapped adults in Montredon, near Narbonne. His commitment to education and academia has seen him as a Visiting Professor at the University of Craiova in Romania and as an Adjunct Professor in the Department of Psychiatry at the University of Edmonton in Alberta. Dr. Michel Bourin has made significant contributions to the field of psychopharmacology and psychiatry, with over 400 original papers and more than 200 educational and review papers published in both French and English. His expertise extends to authorship of 21 books in French, reflecting his deep understanding and commitment to advancing knowledge in his field. With a career spanning decades, Dr. Michel Bourin has held esteemed positions such as Professor of Pharmacology at the University of Nantes from 1985 to 2012 and Psychiatrist at the Nantes academic hospital from 1997 to 2009. He has also served as the Head of Research in Neurobiology of Anxiety and Depression at the University of Nantes from 1988 to 2009. Dr. Michel Bourin's remarkable contributions have been recognized internationally, earning him the title of Doctor Honoris Causa from esteemed institutions such as the University of Tartu in Estonia and the University of Craiova in Romania. He has also played pivotal roles in organizations such as the World Health Organization as an expert on drug dependence from 2000 to 2016 and as the Scientific Secretary of the Athens Congress of the World Federation of Societies of Biological Psychiatry in 2015. Additionally, he served as the Treasurer of the European College of Neuropsychopharmacology from 1995 to 2002, demonstrating his leadership and commitment to advancing the field on a global scale.

José L. Lanciego’s current research focuses on gene therapy approaches for neurodegenerative diseases using non-human primate models. He is the Chair of the International Brain Research Organization Pan-European Committee, a Board Member of the European Brain Council and the International Basal Ganglia Society Council. He has published 135 papers with an h index of 49. In September 2019, he has co-founded Handl Therapeutics B.V. for pushing forward the development of novel therapies for Parkinson’s disease.

Raffaele Pilla, Pharm.D., Ph.D., Doctor Europaeus, received his Master’s degree in Pharmacy at G. d’Annunzio University in Chieti-Pescara, Italy in 2005, where he also served internships at the Cell Physiology Laboratory and Molecular Biology Laboratory. Prior to his degree, he was an Erasmus Student at Faculté de Pharmacie de Reims in Reims, France. He received his Doctor Europaeus in 2010 from Pitié-Salpétrière Institute in Paris, France. Also in 2010, he received his Ph.D. in Biochemistry, Physiology, and Pathology of Muscle at G. d’Annunzio University in Chieti-Pescara, Italy. He was hired as a Postdoctoral Scholar in the Department of Pharmacology and Physiology at the University of South Florida in Tampa, on two research grants respectively funded by the Office of Naval Research (US Navy) and Divers’ Alert Network. He has written and lectured widely on his experiences. Dr. Pilla has been involved in ongoing research at the University of South Florida with the use of ketone esters. The initial work, funded by the Office of Naval Research, focused on using ketone esters to prevent CNS oxygen toxicity. Dr. Pilla is working to coordinate efforts in the United States and Italy to expand the ketone ester research to other conditions such as epilepsy and cancer and its use as an alternative metabolic fuel. Dr. Pilla has also served extensively in various international medical missions, orphan and homeless programs, emergency medicine rescue and training, and animal rescue and fostering. He is fluent in Italian, English, French, and Spanish. He has a special interest in journalism and photography, and he enjoys sailing, SCUBA diving, ultralight airplane piloting, soccer, volleyball, jogging, and motorcycles.

Dr. Mohita Shrivastava, Ph.D is an internationally trained Neuroscientist & Founder & CEO of the Cognitome Program, Cognitome LLC, Dubai. She holds a Ph.D. degree in the field of Neurosciences from Neurosciences Centre, AIIMS, New Delhi, India & her Ph.D research training from Kansas University Medical Centre, Kansas, USA. She holds two master’s degrees one in Biomedical Sciences from Dr, BR Ambedkar Centre for Biomedical Research, University of Delhi and other in Applied Clinical Psychology from Annamalai University. She also holds an Advanced PG Diploma in Applied Neuropsychology from the University of Bristol, United Kingdom. With more than a decade of experience in the industry, Dr. Shrivastava has been involved in Neuroscience and Neuropsychology teaching, research, therapeutics, projects, and outreach. She is the editorial board member for internationally acclaimed neuroscience journals & holds active membership of several esteemed international neuroscience societies dedicated to research and development in neurosciences. She has published peer-reviewed articles in international journals and columns on mental health in leading newspapers and magazines such as Khaleej Times (UAE’s National Daily), WKND Magazine and Passion Vista Global Magazine. Throughout her illustrious career, Dr. Shrivastava has received many awards and accolades and has been recently selected as Top Neuroscientist of the Year 2024 by the International Association of Top Professionals (IAOTP), NY, USA for her outstanding leadership, dedication, and commitment to the industry. She has also been awarded Global Mental Health Advocacy Leadership Award by Integrated Health & Wellness Council @10th IHW Summit in September 2024, Dubai. Dr. Shrivastava has been conferred with Outstanding Leadership Award in June 2023 and Visionaries Award in February 2024 in Dubai, UAE by Health 2.0 conferences. The Cognitome Program, a structured, neuroscientific, and holistic program, led by Dr. Shrivastava is a pioneering initiative effectively addresses issues related with cognition, cognitive impairment and age-related cognitive decline and offer therapeutic interventions and management for a wide range of brain and behavioral issues. By combining principles of neuroscience and neuropsychology, the program helps individuals tap into the brain's resources, by exploiting the concept of neuroplasticity and enabling personal and professional growth at any age or stage of life. The Cognitome Program, Cognitome LLC has been conferred with Outstanding Organization Award in Las Vegas, USA 2024 by Health 2.0 Conferences.

Will be updated soon...

Dr Cho’s main research interests have been focusing on cancer studies to discover biomarkers for cancer diagnosis, treatment prediction and prognostication. As a seasoned researcher, Dr Cho hasconducted cancer research in using molecular biology, proteomics, genomics, immunology as well as bioinformatics, his current H-index is about 100. Dr. Cho has published more than 600 peer-reviewed papers (Lancet, Lancet Oncology, Annals of Oncology, Lancet Gastroenterology & Hepatology, Advanced Science, Nature Communications,PNAS,Molecular Cancer,Journal of Thoracic Oncology,Journal of the National Cancer Institute,Journal of Extracellular Vesicles, Clinical Cancer Research, Clinical Chemistry, Theranostics, etc.) covering cancer biomarkers, proteomics, non-coding RNA, traditional Chinese medicine, and dozens of books (including “An Omics Perspective on Cancer Research”, “MicroRNAs in Cancer Translational Research”, “Drug Repurposing in Cancer Therapy: Approaches and Applications”, “Supportive Cancer Care with Chinese Medicine” and “Resistance to Anti-CD20 antibodies and approaches for their reversal”, etc).

Will be updated soon...

Kadir Uludag holds Ph.D. in Applied psychology (Chinese Academy of Sciences). He is currently doing postdoc in Shanghai Jiaotong University Mental Health Center. His research interest includes schizophrenia research, drug addiction and educational psychology. In addition, he runs a website to share and comment on peer-reviewed articles.

Dr. Kalliopi Megari is a Postdoctoral researcher of Aristotle University of Thessaloniki, Greece, Academic Director of MSc in Clinical Psychology and Clinical supervisor at City College, University of York, Europe Campus. She is Adjunct lecturer at University of Western Macedonia in Florina, Greece. Dr.Megari is a psychologist with a history of working in the hospital & health care industry, skilled in Clinical Neuropsychology, Clinical Research, Medical Education, Psychological Assessment and Learning Disabilities. She works both in clinical and in research practice and she provides strong professional healthcare services, graduated from Aristotle University of Thessaloniki, and attended further education from Department of Educational and Social Policy, University of Macedonia, in people with special needs and disabilities. She holds undergraduate degrees in Nursing and Psychology, as well as a Master’s and a PhD in Neuropsychology from Aristotle University of Thessaloniki. She has some years of occupational and research experience working with patients who have neurological, psychiatric, and cognitive disorders, as well as chronic disease patients suffering from cancer and cardiovascular diseases. She is the head of the Centre of creative activities of children and adults with disabilities and she also works as a counseling psychologist in Prison, Diavata Thessaloniki, at the school of second chance. She was the Global Engagement Representative of SLC International Neuropsychological Society from 2018-2021 and she was a research fellow in the Department of Cardiovascular Surgery in AHEPA Hospital. Currently she is a Global Membership Committee member of International Neuropsychological Society and leader of Rehabilitation of COVID-19 patients working group of Neuro COVID International Neuropsychology Taskforce SIG. In addition, she is the General Secretary of the board of directors of Hellenic Neuropsychological Society and Ethics Committee president of Hellenic Neuropsychological Society. Since 2021, she is a member of PIAC Community Outreach Subcommittee of AMERICAN PSYCHOLOGICAL ASSOCIATION Membership and a member of Engagement Committee of American Group Psychotherapy Association (AGPA). Her work has earned her many prestigious international awards and was an Ambassador of National Academy of Neuropsychology (NAN), USA Leadership and Ambassador Development Program(2022-23). She has given lectures at Aristotle University of Thessaloniki, University of Warsaw and Norwegian University of Science and Technology in Oslo. She is committed to leadership skills and issues on equity, diversity, and inclusion as her clinical and research work states.

Dr. Srdjan Ljubisavljevic is a Professor at the Department for Neurology in the University Clinical Center of Nis, Serbia, and holding a concurrent position at the Faculty of Medicine in Nis. His illustrious academic journey has taken him through esteemed institutions such as the faculties in Nis, Belgrade, Athens, as well as enriching experiences in London, Rome, Prague, and Leiden. With a fervent dedication to advancing knowledge in his field, Dr. Ljubisavljevic has emerged as a leader in research projects focusing on headaches and pain medicine. His contributions to the scientific community are evident in the numerous publications he has authored, which have found their place in prestigious international scientific journals. Beyond his scholarly pursuits, Dr. Ljubisavljevic is actively engaged as a member of both national and international societies, where he shares his expertise and collaborates with peers from around the globe. His outstanding contributions have been recognized with several awards, not only for his pioneering work in neurology and headaches but also for his overall scientific endeavors, marking him as a beacon of excellence in his field.

Will be updated soon...